0001209191-19-059767.txt : 20191209 0001209191-19-059767.hdr.sgml : 20191209 20191209183641 ACCESSION NUMBER: 0001209191-19-059767 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191205 FILED AS OF DATE: 20191209 DATE AS OF CHANGE: 20191209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oney Sabah CENTRAL INDEX KEY: 0001757776 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 191276264 MAIL ADDRESS: STREET 1: C/O ALECTOR, INC. STREET 2: 151 OYSTER POINT BLVD., #300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462702363 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD., SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD., SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-05 0 0001653087 Alector, Inc. ALEC 0001757776 Oney Sabah C/O ALECTOR, INC. 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Business Officer Common Stock 2019-12-05 4 M 0 1500 8.16 A 595418 D Common Stock 2019-12-05 4 S 0 1500 20.00 D 593918 D Common Stock 2019-12-06 4 M 0 5156 8.16 A 599074 D Common Stock 2019-12-06 4 S 0 5156 20.02 D 593918 D Common Stock 2019-12-09 4 M 0 2300 8.16 A 596218 D Common Stock 2019-12-09 4 S 0 2300 20.07 D 593918 D Stock Option (right to buy) 8.16 2019-12-05 4 M 0 1500 0.00 D 2028-07-01 Common Stock 1500 148100 D Stock Option (right to buy) 8.16 2019-12-06 4 M 0 5156 0.00 D 2028-07-01 Common Stock 5156 142944 D Stock Option (right to buy) 8.16 2019-12-09 4 M 0 2300 0.00 D 2028-07-01 Common Stock 2300 140644 D The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.00 to $20.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.00 to $20.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.00 to $20.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. /s/ Stephanie Yonker, attorney-in-fact 2019-12-09